You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

therapy reponse

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial (Envolimab, Fuquinitinib, Oxaliplatin)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Jun 13, 2023

Crohn's Disease, Ulcerative Colitis Trial (Samples)

Not yet recruiting
  • Crohn's Disease
  • Ulcerative Colitis
  • Samples
  • (no location specified)
Feb 8, 2023

Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Disitamab Vedotin（RC48-ADC）
  • (no location specified)
Jul 13, 2023

Hepatocellular Carcinoma Trial in Berlin, Hannover (Pembrolizumab, Lenvatinib Capsules)

Recruiting
  • Hepatocellular Carcinoma
  • Berlin, Germany
  • +1 more
May 12, 2022

Gastric Cancer Trial (Disitamab Vedotin, Sintilimab, S-1)

Not yet recruiting
  • Gastric Cancer
  • Disitamab Vedotin
  • +3 more
  • (no location specified)
Nov 17, 2022

Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • BTK inhibitor
  • PD-1 inhibitor
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023

Colitis, Ulcerative Trial in Amsterdam (Infliximab)

Recruiting
  • Colitis, Ulcerative
  • Dublin, Ireland
  • +6 more
Dec 2, 2022

Auditory Hallucination, Psychotic Disorders, Schizophrenia and Related Disorders Trial in Hawthorn (Avatar therapy, Cognitive

Recruiting
  • Auditory Hallucination
  • +2 more
  • Avatar therapy
  • Cognitive behavioural therapy (CBT)
  • Hawthorn, Victoria, Australia
    Swinburne University of Technology
Aug 4, 2023

Simple Blood Test to Reduce Unnecessary Adverse Effects From

Not yet recruiting
  • Pathological Response Rate, Circulating Tumour DNA
  • MeD-seq
  • (no location specified)
Sep 6, 2023

A Registry for Patients With Systemic Mastocytosis in China

Not yet recruiting
  • Systemic Mastocytoses
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Aug 24, 2023

    Advanced Pancreatic Cancer and Cholangiocarcinoma Trial in Hangzhou (PRRT with 177Lu-EB-FAPI)

    Recruiting
    • Advanced Pancreatic Cancer and Cholangiocarcinoma
    • PRRT with 177Lu-EB-FAPI
    • Hangzhou, Zhejiang, China
      First Affiliated Hospital of Zhejiang University
    Oct 10, 2023

    Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (BI 765063, Ezabenlimab, BI 836880)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma (HNSCC)
    • BI 765063
    • +4 more
    • Saint Louis, Missouri
    • +15 more
    Aug 10, 2022

    Triple-negative Breast Cancer Trial in China (Chiauranib, capecitabine)

    Recruiting
    • Triple-negative Breast Cancer
    • Guangzhou, Guangdong, China
    • +3 more
    Apr 14, 2022

    NSCLC Trial in Worldwide (Atezolizumab)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • Caba, Argentina
    • +111 more
    May 25, 2022

    HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

    Recruiting
    • HER2-positive Metastatic Breast Cancer
    • Aurora, Colorado
    • +2 more
    Dec 29, 2022

    Gastric Adenocarcinoma, Malignant Melanoma Trial in Seoul (AZD6738, Durvalumab)

    Active, not recruiting
    • Gastric Adenocarcinoma
    • Malignant Melanoma
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)

    Withdrawn
    • Carcinoma, Non-small Cell Lung Cancer
    • nivolumab
    • +5 more
    • Detroit, Michigan
    • +22 more
    Mar 8, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in Nanjing (SHR7390)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Feb 19, 2022

    Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))

    Not yet recruiting
    • Lymphoma Leukemia
    • allogeneic CAR19 regulatory T cells (CAR19-tTreg)
    • +2 more
    • Minneapolis, Minnesota
      Masonic Cancer Center - University of Minnesota
    Dec 6, 2022

    Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

    Recruiting
    • Small Cell Lung Cancer
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    May 4, 2022

    Polymyxin B in Adult Patients With Cystic Fibrosis

    Completed
    • Cystic Fibrosis
    • Polymyxin B
    • Blood Draw
    • Ann Arbor, Michigan
      University of Michigan
    Jul 9, 2021

    Smoking Cessation Trial in Hong Kong (Nicotine Replace Therapy (NRT) sampling, Simple exercise education (SEE), Chat-based

    Recruiting
    • Smoking Cessation
    • Nicotine Replace Therapy (NRT) sampling
    • +3 more
    • Hong Kong, Hong Kong
      Faculty of Medicine
    Oct 4, 2023

    Small Cell Lung Cancer Trial in Beijing (Chiauranib)

    Recruiting
    • Small Cell Lung Cancer
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Mar 8, 2022

    Relapsed or Refractory Follicular Lymphoma Trial in Worldwide (Mosunetuzumab, Lenalidomide, Rituximab)

    Recruiting
    • Relapsed or Refractory Follicular Lymphoma
    • Duarte, California
    • +108 more
    Jul 26, 2022

    Waldenstrom Macroglobulinemia Trial (Venetoclax; Rituximab, DRC)

    Not yet recruiting
    • Waldenstrom Macroglobulinemia
    • Venetoclax; Rituximab
    • DRC
    • (no location specified)
    Nov 4, 2022